Dr Andreas Meyer is Senior Foundry Lead at Ginkgo Bioworks Inc. a renowned US synthetic biology company, for which he is managing the Swiss site in Basel.
He joined Ginkgo in 2022 through the acquisition of FGen AG, an ETH spin-off company he co-founded in 2011 and was heading as CEO since its incorporation.
As an entrepreneur Andreas is particularly interested in technology driven companies and how open innovation can boost product development.
He earned his PhD in Biotechnology from the Swiss Federal Institute of Technology in Zurich for his work on protein engineering.